Core Viewpoint - Ruipai Pet Hospital is set to launch its Hong Kong IPO non-deal roadshow on January 29, 2025, with CICC as the sole sponsor, marking a significant step in its expansion strategy [1] Company Overview - Established in 2012, Ruipai Pet Hospital is a national chain of pet medical institutions in China, focusing on high-standard diagnosis and health management services for pets [1] - The company has developed a nationwide network of pet medical services and pioneered the Veterinary Development Partners (VDP) model, which aims to cultivate a high-level team of veterinarians [1] Market Position - As of June 30, 2025, Ruipai Pet Hospital is the second-largest pet medical service provider in China, operating 548 hospitals, including 120 self-built and 428 acquired hospitals across 70 cities in 28 provinces [1] Financial Performance - Ruipai Pet Hospital is the only large national chain pet hospital service provider that has achieved net profit as of June 30, 2025 [2] - The company has established a mature hospital management system and profit model, demonstrating operational efficiency during its expansion [2] - Financial results show revenues of approximately 1.455 billion RMB for 2022, 1.585 billion RMB for 2023, 1.758 billion RMB for 2024, and 943 million RMB for the six months ending June 30, 2025 [2] - The total comprehensive income for the same periods were approximately -61.86 million RMB, -250 million RMB, -7.126 million RMB, and 15.277 million RMB respectively [2]

Group 1 - The core viewpoint of the article is that Ruipai Pet Hospital Management Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CICC as the sole sponsor [1] - As of June 30, 2025, the company is projected to become the second-largest pet medical service provider in China, operating 548 pet hospitals, which include 120 self-built hospitals and 428 acquired hospitals [1] - The hospitals are distributed across mainland China and Hong Kong, covering approximately 70 cities in 28 provinces [1] Group 2 - The company is a national chain of pet medical institutions, committed to providing high-standard diagnosis and full lifecycle health management services for pets, based on the principles of professionalism, dedication, and expertise [5]